NVCR - Novocure Ltd

Insider Purchase by Cordova Ashley (CEO)

6 Months
After Trade
Before Trade

Loading data...

Trade Summary

5 months ago, Cordova Ashley, serving as CEO at Novocure Ltd (NVCR), purchased 81,550 shares at $12.22 per share, for a total transaction value of $996,859.00. Following this transaction, Cordova Ashley now holds 437,569 shares of NVCR.

This purchase represents a 23.00% increase in Cordova Ashley's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, September 5, 2025 and publicly disclosed via SEC Form 4 filing on Monday, September 8, 2025, 3 days after the trade was made.

Novocure Ltd operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Cordova Ashley

CEO

Ashley Cordova is a seasoned finance executive who served as Chief Executive Officer (CEO) of Novocure Ltd (NVCR) from January 1, 2025, until her resignation on November 24, 2025, by mutual agreement, remaining on payroll through May 2026[[3]](https://www.fiercebiotech.com/medtech/novocure-taps-leonard-ceo-replacing-cordova-after-year)[[5]](https://app.boardroomalpha.com/profiles/people/A1356972-ASHLEY_CORDOVA)[[6]](https://www.mddionline.com/radiological/novocure-appoints-new-ceo-after-cordova-s-short-tenure). Prior to her CEO role, she was Chief Financial Officer (CFO) since September 2020, overseeing global revenue, financial operations, and investor relations, after joining Novocure in 2014 (with some sources noting 2016 as her start in finance and investor relations)[[1]](https://www.comparably.com/companies/novocure/ashley-cordova)[[2]](https://www.greenvillebusinessmag.com/2024/09/16/505240/furman-grad-named-novocure-ceo)[[4]](https://www.mpo-mag.com/breaking-news/novocures-ceo-to-retire-cfo-ashley-cordova-to-take-over-role/)[[5]](https://app.boardroomalpha.com/profiles/people/A1356972-ASHLEY_CORDOVA). She succeeded Asaf Danziger, who retired at the end of 2024 but continued as a senior advisor into 2026[[2]](https://www.greenvillebusinessmag.com/2024/09/16/505240/furman-grad-named-novocure-ceo). A native of St. Louis, Missouri, Cordova graduated from Furman University in 2001 with a bachelor’s degree in music and business, followed by an International Master of Business Administration from the University of South Carolina's Darla Moore School of Business in 2005[[2]](https://www.greenvillebusinessmag.com/2024/09/16/505240/furman-grad-named-novocure-ceo). Her career includes prior roles at Zoetis Inc. and Pfizer Inc., and she was noted as Novocure's first female CEO, leading the medical technology company focused on Tumor Treating Fields therapy for cancers like glioblastoma[[2]](https://www.greenvillebusinessmag.com/2024/09/16/505240/furman-grad-named-novocure-ceo)[[3]](https://www.fiercebiotech.com/medtech/novocure-taps-leonard-ceo-replacing-cordova-after-year). At 45 during her appointment, she is married with two teenagers and was preparing a move from outside Philadelphia to Zurich[[2]](https://www.greenvillebusinessmag.com/2024/09/16/505240/furman-grad-named-novocure-ceo).

View full insider profile →

Trade Price

$12.22

Quantity

81,550

Total Value

$996,859.00

Shares Owned

437,569

Trade Date

Friday, September 5, 2025

170 days ago

SEC Filing Date

Monday, September 8, 2025

Filed 3 days after trade

HEALTHCAREMEDICAL DEVICES

About Novocure Ltd

Company Overview

No company information available
View news mentioning NVCR

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/243120

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime